TECHDOW PHARMA ENGLAND LIMITED
Get an alert when TECHDOW PHARMA ENGLAND LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£6.8m
-28.6% vs 2024
Net assets
-£1.1m
+44.4% highest in 6 filed years
Employees
12
+9.1% highest in 6 filed years
Profit before tax
£1.2m
+19.1% first positive since 2021
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Negative shareholders' funds
Net assets
6-year trend · vs Consumer Discretionary median
Accounts
6-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|---|---|---|
| Turnover | £23,020,829 | £31,674,721 | £42,844,591 | £49,912,155 | £39,675,728 | £48,765,902 | +22.9% | |
| Operating profit | -£1,167,354 | -£6,601,447 | £5,533,931 | £4,716,550 | £999,937 | £1,121,528 | +12.2% | |
| Profit before tax | -£1,170,969 | -£6,626,980 | £5,485,081 | £4,658,091 | £974,795 | £1,160,719 | +19.1% | |
| Net profit | -£1,170,969 | -£6,626,980 | £5,439,048 | £5,605,796 | £730,293 | £870,504 | +19.2% | |
| Cash | £5,639,057 | £9,230,843 | £10,272,487 | £13,885,969 | £9,478,356 | £6,764,715 | -28.6% | |
| Total assets less current liabilities | -£7,108,716 | -£13,735,696 | -£8,296,648 | -£2,690,852 | -£1,960,559 | -£1,090,055 | +44.4% | |
| Net assets | -£7,108,716 | -£13,735,696 | -£8,296,648 | -£2,690,852 | -£1,960,559 | -£1,090,055 | +44.4% | |
| Equity | -£7,108,716 | -£13,735,696 | -£8,296,648 | -£2,690,852 | -£1,960,559 | -£1,090,055 | +44.4% | |
| Average employees | 8 | 8 | 8 | 10 | 11 | 12 | +9.1% | |
| Wages | £850,728 | £542,206 | £925,903 | £904,059 | £1,218,183 | £1,287,841 | +5.7% | |
| Directors' remuneration | — | — | — | £0 | £0 | — | — | |
| Directors' pension contributions | — | — | — | £0 | £0 | — | — | |
| Highest paid director | — | — | — | £0 | £0 | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|---|---|
| Operating margin | -5.1% | -20.8% | 12.9% | 9.4% | 2.5% | 2.3% | |
| Net margin | -5.1% | -20.9% | 12.7% | 11.2% | 1.8% | 1.8% | |
| Gearing (liabilities / total assets) | — | — | — | 107.6% | 104.6% | 102.3% | |
| Current ratio | — | — | — | 0.93x | 0.96x | 0.98x | |
| Interest cover | — | — | — | 80.68x | 38.96x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Forvis Mazars
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements are prepared on a going concern basis. The Company remains assured of the financial support provided by Shenzhen Hepalink Pharmaceutical Group Co., Ltd., the ultimate controlling party.”
Significant events
- “There have been no significant events affecting the Company since the year end.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CHEN, Juan | Director | 2024-05-01 | Oct 1975 | Chinese |
| GEORGE, Paula | Director | 2023-03-01 | Aug 1964 | British |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| PINSENT MASONS SECRETARIAL LIMITED | Corporate Secretary | 2016-12-06 | 2017-08-31 |
| HIGGINS, Stephen John | Director | 2017-08-01 | 2020-04-30 |
| LI, Jianke | Director | 2017-12-01 | 2019-08-27 |
| LING, Xing | Director | 2019-08-27 | 2020-06-29 |
| SHI, Wen | Director | 2020-06-29 | 2023-08-23 |
| ZIEBA, Rafal Piotr | Director | 2016-12-06 | 2017-08-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Techdow Pharma Netherlands Bv | Corporate entity | Significant influence | 2020-04-01 | Active |
| Rafal Piotr Zieba | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-12-06 | Ceased 2020-03-30 |
Filing timeline
Last 20 of 45 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-30 | AA | accounts | Accounts with accounts type full | |
| 2026-01-06 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-12-17 | AA | accounts | Accounts with accounts type full | |
| 2025-01-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-25 | AA | accounts | Accounts with accounts type full | |
| 2024-05-02 | AP01 | officers | Appoint person director company with name date | |
| 2023-12-07 | AA | accounts | Accounts with accounts type full | |
| 2023-12-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-23 | TM01 | officers | Termination director company with name termination date | |
| 2023-03-09 | AP01 | officers | Appoint person director company with name date | |
| 2022-12-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-11-30 | AA | accounts | Accounts with accounts type full | |
| 2021-12-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-10-07 | AA | accounts | Accounts with accounts type full | |
| 2021-04-27 | AA | accounts | Accounts with accounts type full | |
| 2021-04-23 | DISS40 | gazette | Gazette filings brought up to date | |
| 2021-04-20 | GAZ1 | gazette | Gazette notice compulsory | |
| 2020-12-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-07-08 | AP01 | officers | Appoint person director company with name date | |
| 2020-07-07 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.